Glaucoma-related vision loss may increase risk for auto accidents
The first study to compare accident rates for drivers who have advanced glaucoma − an eye disease that affects peripheral vision − with normal-vision drivers, found that the glaucoma group had about twice as many accidents. This study, which was conducted in Japan using a driving simulator, suggests that potential drivers should pass a visual field test to ensure adequate peripheral vision before a license is granted or renewed. The research is being presented today at the 116th Annual Meeting of the American Academy of Ophthalmology, jointly conducted this year with the Asia-Pacific Academy of Ophthalmology.
Glaucoma, which is an age-related eye disease, can partially or severely restrict a person’s peripheral vision, without damaging their central vision or visual acuity. (Click here to see how glaucoma can affect vision.) This means that many people who have the disease would be able to pass the only vision test now required for a driver’s license in most countries, known as the visual acuity test. Drivers need good peripheral vision in order to assess and keep up with the flow of traffic, stay in the proper lane, and detect stop lights, pedestrians, vehicles and other obstacles.
In this study, which was conducted at Tohoku University Graduate School of Medicine, in Sendai, Japan, two groups of 36 people each were tested using a driving simulator. People in group one had advanced glaucoma and those in group two had normal vision. The groups were matched for age, driving experience and other characteristics. The most common accident scenario for both the glaucoma and normal-vision groups was when a child, car, or other object suddenly entered the driver’s path from the side. The glaucoma group, however, had more than twice as many collisions as the normal-vision group.
Glaucoma affects more than 2.7 million Americans age 40 and older. It is the second leading cause of blindness worldwide. If untreated, glaucoma reduces peripheral vision and eventually causes blindness by damaging the optic nerve.
This essential nerve sends signals from the retina - a layer of light-sensitive tissue at the back of the eye - to the brain, where these signals are interpreted as the images people see. Only half of the people who have glaucoma are aware of it , since the disease is painless and vision loss is very gradual.
As populations grow older worldwide, health officials are exploring measures that will ensure safety on the roads. For instance, in the United States., visual field requirements vary from state to state with 12 of the 51 jurisdictions restricting licenses for those with visual impairments. Some states or territories require the installation of additional mirrors on the vehicles of these drivers.
1. Glaucoma is a leading cause of blindness
Glaucoma can cause blindness if it is left untreated. And unfortunately approximately 10% of people with glaucoma who receive proper treatment still experience loss of vision.
2. There is no cure (yet) for glaucoma
Glaucoma is not curable, and vision lost cannot be regained. With medication and/or surgery, it is possible to halt further loss of vision. Since open-angle glaucoma is a chronic condition, it must be monitored for life. Diagnosis is the first step to preserving your vision.
3. Everyone is at risk for glaucoma
Everyone is at risk for glaucoma from babies to senior citizens. Older people are at a higher risk for glaucoma but babies can be born with glaucoma (approximately 1 out of every 10,000 babies born in the United States). Young adults can get glaucoma, too. African Americans in particular are susceptible at a younger age.
4. There may be no symptoms to warn you
With open-angle glaucoma, the most common form, there are virtually no symptoms. Usually, no pain is associated with increased eye pressure. Vision loss begins with peripheral or side vision. You may compensate for this unconsciously by turning your head to the side, and may not notice anything until significant vision is lost. The best way to protect your sight from glaucoma is to get tested. If you have glaucoma, treatment can begin immediately.
“To help ensure everyone’s safety on our roadways, we would like to create mandatory vision testing guidelines for glaucoma patients,” said Shiho Kunimatsu-Sanuki, M.D., lead researcher on the study. “We now know that integrating the visual field test into the requirements for a driver’s license could save lives.”
With proper medical care, many people with glaucoma can maintain a level of vision that would enable safe driving. The American Academy of Ophthalmology recommends that everyone have a complete eye exam at age 40, so that glaucoma and other age-related eye diseases can be diagnosed and treated early to minimize vision loss.
Glaucoma is the second leading cause of irreversible blindness worldwide. The disease affects about 5 million Americans, mostly over age forty. Distressingly, many of these individuals are unaware of their affliction until long after the optic nerve has already been permanently damaged.
The term “glaucoma” refers to a group of similar conditions that damage the retina and optic nerve, leading to visual impairment. Glaucoma is sometimes called a “silent thief” because it slowly robs its victims of peripheral vision, which can go unnoticed until the loss becomes significant enough to interfere with everyday life.
Although glaucoma-related vision loss is not reversible, the progression of the disease can nearly always be slowed or halted. When diagnosed and treated early, it seldom leads to blindness.
Prescription medications and surgery can control the clinical manifestations, but the most commonly prescribed drugs carry unpleasant side effects, while there are risks associated with surgery.
Fortunately, recent scientific studies have illuminated natural strategies to help attenuate the progression of glaucoma. Investigations have shown that a combination of plant-based interventions derived from French maritime pine bark and bilberry target one of the most common underlying problems with glaucoma: increased pressure in the front of the eye, a condition known as elevated intraocular pressure (IOP).
Human studies reveal that these natural compounds complement conventional glaucoma medications as well, acting synergistically to optimize intraocular pressure (Steigerwalt 2010).
###
The 116th Annual Meeting of the American Academy of Ophthalmology is in session November 10-13 at McCormick Place in Chicago. It is the world’s largest, most comprehensive ophthalmic education conference. More than 25,000 attendees and 500 companies gather each year to showcase the latest in ophthalmic education, research, clinical developments, technology, products and services. This year’s meeting is being held in partnership with the Asia-Pacific Academy of Ophthalmology.
Note to media: Contact Media Relations to request full text of the study and arrange interviews with experts
About the American Academy of Ophthalmology
The American Academy of Ophthalmology is the world’s largest association of eye physicians and surgeons - Eye M.D.s - with more than 32,000 members worldwide. Eye health care is provided by the three “O’s” – ophthalmologists, optometrists, and opticians. It is the ophthalmologist, or Eye M.D., who can treat it all: eye diseases, infections and injuries, and perform eye surgery. For more information, visit http://www.aao.org The Academy’s EyeSmart® program educates the public about the importance of eye health and empowers them to preserve healthy vision. EyeSmart provides the most trusted and medically accurate information about eye diseases, conditions and injuries. OjosSanos™ is the Spanish-language version of the program.